Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population

NCT07587151 | Completed

• 2 other identifiers: 2264549 - UICOM RockfordUIC Diabetes Center Pilot
• Study Type: interventional
• Target: 46
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to improve T2DM (type 2 diabetes mellitus) management and health outcomes among underserved patients who receive primary care at a federally qualified health center (FQHC) in Winnebago County, Illinois. Our aim is to assess the feasibility and preliminary effectiveness of a pilot program combining continuous glucose monitoring (CGM) with monthly telehealth appointments to improve diabetes management in FQHC patients who have uncontrolled T2DM (HbA1c \>7%). Researchers will compare those who receive the intervention (usual in-person care + CGM + 2 telehealth visits with a clinical pharmacist and family medicine resident) with those receiving a CGM in additional to usual care (in-person care + CGM). Participants will have their HbA1c tested and complete surveys to assess diabetes-related distress and diabetes management self-efficacy at baseline and 3 and 6 months from baseline. This will allow the investigators to raise glucose awareness for all participants utilizing CGM technology while simultaneously determining the necessity of more frequent follow-up than the guideline recommended intervals of 3 months for uncontrolled diabetes in an under-resourced population. This will also allow us to evaluate the feasibility of telehealth in delivering more frequent follow-up care to patients with T2DM.

Conditions

Type 2 Diabetes

Keywords

diabetes; continuous glucose monitor; telehealth; federally qualified health center

Outcome Measures

Primary Outcomes (1)

• HbA1c

  Hemoglobin A1c

  Enrollment, 3 months, and 6 months

Secondary Outcomes (2)

• Diabetes-related distress

  Enrollment, 3 months, and 6 months

• Diabetes Management Self-Efficacy

  Baseline, 3 months, and 6 months

Study Arms (2)

CGM + telehealth

EXPERIMENTAL

In addition to usual care for patients with poorly controlled diabetes, participants will receive a CGM plus education on its use and 2 telehealth appointments, 1 month and 2 months from their initial appointment. The telehealth appointments will be conducted by a clinical pharmacist and family medicine resident physician and will be used to discuss CGM outcomes and treatment planning.

Other: CGM plus telehealth

CGM only

ACTIVE COMPARATOR

In addition to usual care for patients with poorly controlled diabetes, participants will receive a CGM plus education on its use.

Other: CGM only

Interventions

CGM plus telehealth OTHER

Participants will receive CGM supplies for 3 months plus 2 monthly telehealth appointments.

CGM + telehealth

CGM only OTHER

Participants will receive CGM supplies for 3 months

CGM only

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient receiving primary care from the study clinical site
• Uncontrolled T2DM (HbA1c \>7%)
• years of age and older

You may not qualify if:

• Patients younger than 18 years of age
• Patients in correctional facilities
• Pregnant or lactating women
• Current Continuous Glucose Monitoring device (CGM) users
• Patients with gestational diabetes mellitus or Type 1 diabetes mellitus

Sponsors & Collaborators

• University of Illinois at Chicago: lead

Study Sites (1)

University of Illinois College of Medicine Rockford

Rockford, Illinois, 61107, United States

Location

Related Publications (5)

• Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012 Jan;35(1):32-8. doi: 10.2337/dc11-1438. Epub 2011 Nov 18.

  PMID: 22100963 BACKGROUND

• Patel PM, Thomas D, Liu Z, Aldrich-Renner S, Clemons M, Patel BV. Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: Key themes and evidentiary gaps. Diabetes Obes Metab. 2024 Oct;26(10):4293-4301. doi: 10.1111/dom.15774. Epub 2024 Jul 15.

  PMID: 39010293 BACKGROUND

• Uhl S, Choure A, Rouse B, Loblack A, Reaven P. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2024 Mar 15;109(4):1119-1131. doi: 10.1210/clinem/dgad652.

  PMID: 37987208 BACKGROUND

• Wallia A, Agarwal S, Owen AL, Lam EL, Davis K, Bailey SC, DeLacey SE, Pack AP, Espinoza J, Bright D, Eggleston A, Walter E, O'Brien MJ. Disparities in Continuous Glucose Monitoring Among Patients Receiving Care in Federally Qualified Health Centers. JAMA Netw Open. 2024 Nov 4;7(11):e2445316. doi: 10.1001/jamanetworkopen.2024.45316.

  PMID: 39576644 BACKGROUND

• Myers A, Presswala L, Bissoonauth A, Gulati N, Zhang M, Izard S, Kozikowski A, Meyers K, Pekmezaris R. Telemedicine for Disparity Patients With Diabetes: The Feasibility of Utilizing Telehealth in the Management of Uncontrolled Type 2 Diabetes in Black and Hispanic Disparity Patients; A Pilot Study. J Diabetes Sci Technol. 2021 Sep;15(5):1034-1041. doi: 10.1177/1932296820951784. Epub 2020 Aug 29.

  PMID: 32865027 BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2; Diabetes Mellitus

Interventions

Continuous Glucose Monitoring; Telemedicine

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Blood Chemical Analysis; Clinical Chemistry Tests; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Diagnostic Techniques, Endocrine; Monitoring, Physiologic; Investigative Techniques; Delivery of Health Care; Patient Care Management; Health Services Administration

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: May 8, 2026
• First Posted: May 14, 2026
• Study Start: March 31, 2025
• Primary Completion: December 5, 2025
• Study Completion: April 28, 2026
• Last Updated: May 14, 2026

Record last verified: 2026-05

Locations

US (1)